FDA
-
-
-
-
-
-
-
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Raised to $15 at H.C. Wainwright
-
-
-
-
-
-
-
FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Raised to $23 at H.C. Wainwright
-
-
-
-
-
-
-
Stifel on Lexeo Therapeutics (LXEO): 'FA-CM Data Look Promising Though Handful of Questions for 8AM Call'
-
-
-
-
-
-
-
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
-
-
-
-
-
323,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

